Austin J. Livingston

Austin J. Livingston

Surgery, Duke University Hospital, Durham, California, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
FHFrancis Monroe Hughes
Francis Monroe Hughes
MOMichael R. Odom
Michael R. Odom
ACAnissa Cervantes
Anissa Cervantes
ALAustin J. Livingston
Austin J. Livingston
JPJ. Todd Purves
J. Todd Purves
Anecdotal evidence has long suggested that patients with lower urinary tract symptoms (LUTS) develop mood disorders, such as depression and anxiety, at a higher rate than the general population and recent prospective studies have confirmed this link. Breakthroughs in our understanding of the diseases underlying LUTS have shown that many have a substantial inflammatory component and great strides have been made recently in our understanding of how this inflammation is triggered. Meanwhile, studies on mood disorders have found that many are associated with central neuroinflammation, most notably in the hippocampus. Excitingly, work on other diseases characterized by peripheral inflammation has shown that they can trigger central neuroinflammation and mood disorders. In this review, we discuss the current evidence tying LUTS to mood disorders, its possible bidirectionally, and inflammation as a common mechanism. We also review modern theories of inflammation and depression. Finally, we discuss exciting new animal studies that directly tie two bladder conditions characterized by extensive bladder inflammation (cyclophosphamide-induced hemorrhagic cystitis and bladder outlet obstruction) to neuroinflammation and depression. We conclude with a discussion of possible mechanisms by which peripheral inflammation is translated into central neuroinflammation with the resulting psychiatric concerns.

1 November 2020 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
ALAustin J. Livingston
Austin J. Livingston
BLBrandon Laing
Brandon Laing
NZNathan T. Zwagerman
Nathan T. Zwagerman
MHMichael S. Harris
Michael S. Harris

1 September 2023 in Journal of Endourology
Verified
Journal Article
Closed access
ALAustin J. Livingston
Austin J. Livingston
TDThomas Dvergsten
Thomas Dvergsten
Tara Nikonow MorganTara Nikonow Morgan
Tara Nikonow Morgan
Background: There is a paucity of guidelines for prostate-specific antigen (PSA) monitoring after simple prostatectomy (SP) despite these patients remaining at risk for prostate cancer (PCa). Our objective was to determine if PSA kinetics can be a potential indicator of PCa after SP. Methods: A retrospective review was performed of all simple prostatectomies at our institution from 2014 to 2022. All patients who met criteria were included in the study. Relevant clinical variables were collected preoperatively, including PSA value, prostate size, and voiding symptoms. Surgical and urinary function outcomes were analyzed. Results: A total of 92 patients were divided into two groups based on malignancy status. Sixty-eight patients did not have PCa, while 24 patients had known PCa before surgery (14) or were diagnosed as having incidental PCa from the pathological specimen (10). Patients with benign prostates had an initial postoperative PSA value of 0.76 ng/mL compared with 1.68 ng/mL for those with cancer ( p < 0.01). PSA velocity for the first 24 months after surgery was 0.042 ± 1.61 ng/(mL·year) for the benign cohort compared with 1.29 ± 1.02 ng/(mL·year) for the malignant cohort ( p = 0.01). Voiding improvements were noted by objective (postvoid residual and flow rate) and subjective (American Urological Association symptom score and quality of life score) measures in both groups. Conclusions: PSA interpretation and monitoring after SP have not been well established. Our study indicates that initial postoperative PSA value and PSA velocity are important indicators of underlying malignancy in patients after SP. Further efforts are needed to establish threshold values and formal guidelines.

16 May 2022 in Journal of Surgical Research
Verified
Journal Article
Closed access
ESErin A. Strong
Erin A. Strong
ALAustin J. Livingston
Austin J. Livingston
MGMaciej Gracz
Maciej Gracz
WPWendy Peltier
Wendy Peltier
STSusan Tsai
Susan Tsai
CCCallisia N. Clarke
Callisia N. Clarke

16 August 2024 in Continence
Verified
Journal Article
Open access
ALAustin J. Livingston
Austin J. Livingston
JPJ. Todd Purves
J. Todd Purves
MOMichael R. Odom
Michael R. Odom
HJHuixia Jin
Huixia Jin
FHFrancis Monroe Hughes
Francis Monroe Hughes
Diabetic bladder dysfunction (DBD) is the most common diabetic complication. Patients present with overactive symptoms, underactive symptoms, or both. While strict glucose control may be expected to reverse DBD, prior studies have not been supportive. However, we hypothesize that strict control, soon after hyperglycemia appears, can prevent DBD development. Moreover, 50% of adult diabetics are poorly-controlled and it is unknown how this effects development of DBD. Thus, we investigated the effect of early glucose control (poor and strict) on DBD in male Akita diabetic mice (type 1). NLRP3-induced inflammation is critical to development of DBD in female Akita. Therefore, we also hypothesized that targeting NLRP3 may control or prevent DBD in male Akita, especially in a poorly-controlled population. Akita mice (±NLRP3) were stratified into uncontrolled, poorly-controlled and strictly-controlled diabetic groups using insulin treatment (0, 0.125 or 0.25 U/day). Mice were assessed at 15 weeks for blood glucose, HbA1c, Evans blue dye extravasation (a marker of capillary permeability/inflammation) and bladder function. Blood glucose was elevated in diabetics, reduced in an insulin dose-dependent manner, and not affected by NLRP3 deletion. HbA1c levels followed a similar course but were more sensitive to insulin levels. Evans blue dye extravasation was prevented with glucose control and absent in NLRP3-/- mice. Diabetics exhibited signs of underactive bladder (increased void volume, decreased frequency) that was attenuated in the uncontrolled group but absent in the well-controlled group. Deleting NLRP3 did not affect voiding function. Male Akita mice develop an underactive-like bladder, independent of NLRP3, which can be prevented with glucose control.

16 March 2026 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
ALAustin J. Livingston
Austin J. Livingston
DSDaniel Segal
Daniel Segal
SASarah Attia
Sarah Attia
TDThomas Dvergsten
Thomas Dvergsten
JGJeffrey C. Gahan
Jeffrey C. Gahan
TMTara N. Morgan
Tara N. Morgan